A healthcare company based out of North Carolina is turning heads so far during Tuesday’s session after the company announced that it plans to submit its Dordaviprone for...

To read the full story on AllPennyStocks.com, click here.

Chimerix (NASDAQ:CMRX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Chimerix.
Chimerix (NASDAQ:CMRX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Chimerix.